2-芳胺基-5-[5’-氨基-1’-(4”-氯苯基)-1’,2’,3’-三唑-4’-基]——1,3,4-噁二唑的合成

利用1-[5’-氨基-1’-(4”-氯苯基)-1’,2’,3’-三唑-4’-甲酰基]-4-芳基氨基硫脲在汞盐Hg(OAc)_2-HOAc中加热缩合,制得11种新的2-芳胺基-5-[5’-氨基-1’-(4”-氯苯基)-1’,2’,3’-三唑-4’-基]-1,3,4-噁二唑。所有化合物的结构经元素分析,IR、MS以及~1HNMR确认。选择代表物作生测试验,结果表明,2b,2k在MIC3.1mg/L时,对大肠杆菌及金黄色葡萄球菌繁殖有明显抑制。     

N-(5-邻氯苯基-2-呋喃甲酰氨基)丙氨酰胺衍生物的合成和 生物活性测定

以5-邻氯苯基-2-呋喃甲酰氯和丙氨酸为起始原料, 通过非均相法得到N-(5-邻氯苯基-2-呋喃甲酰氨基)丙氨酸, 再与10种不同取代苯胺反应, 通过N,N’-二环己基碳二亚胺和4-二甲氨基吡啶(DCC/DMAP)偶合法设计合成了10个未见文献报道的N-(5-邻氯苯基-2-呋喃甲酰氨基)丙氨酰胺类衍生物4a～4j. 通过元素分析, 1H NMR, IR 和MS确定化合物的结构, 初步生物活性测试表明标题化合物具有一定的除草活性.     

2-取代氨基-5-吡唑基-1,3,4-噁二唑的合成及生物活性

取代氨基吡唑基噁二唑;2-取代氨基-5-吡唑基-1;3;4-噁二唑的合成及生物活性     

2-[5'-CH3(H)-苯并咪唑-2'-亚甲硫基]-5-取代-1,3,4-(口恶)二唑的合成及生长素活性

以邻苯二胺(或4-甲基邻苯二胺)及一氯乙酸为原料,在酸性条件下,合成2-氯甲基苯并咪唑及2-氯甲基-5-甲基苯并咪唑;以取代羧酸为原料经酯化、肼解、再与CS2在氢氧化钾溶液中反应,合成10种2-巯基-5-取代-1,3,4-(口恶)二唑;将2种2-氯甲基-5-取代-苯并咪唑与10种2-巯基-5-取代-1,3,4-(口恶)二唑在氢氧化钠溶液中反应,合成14种2-[5’-CH3(H)-苯并咪唑-2’-亚甲硫基]-5-取代-1,3,4-(口恶)二唑衍生物.借助红外光谱、核磁共振氢谱和元素分析对化合物结构进行表征.初步生长素活性测试结果表明,所合成的化合物对小麦芽鞘和绿豆发芽有着不同程度的生长调节作用.     

2-[5'-CH3(H)-苯并咪唑-2'-亚甲硫基]-5-取代-1,3,4-噁二唑的合成及生长素活性

以邻苯二胺(或4-甲基邻苯二胺)及一氯乙酸为原料,在酸性条件下,合成2-氯甲基苯并咪唑及2-氯甲基-5-甲基苯并咪唑;以取代羧酸为原料经酯化、肼解、再与CS2在氢氧化钾溶液中反应,合成10种2-巯基-5-取代-1,3,4-噁二唑;将2种2-氯甲基-5-取代-苯并咪唑与10种2-巯基-5-取代-1,3,4-噁二唑在氢氧化钠溶液中反应,合成14种2-[5’-CH3(H)-苯并咪唑-2’-亚甲硫基]-5-取代-1,3,4-噁二唑衍生物。借助红外光谱、核磁共振氢谱和元素分析对化合物结构进行表征。初步生长素活性测试结果表明,所合成的化合物对小麦芽鞘和绿豆发芽有着不同程度的生长调节作用。     

1-(1-乙基-1H-5-吲哚基)-2-苯基-1,2-二酮缩合成1,2,4-三嗪类化合物反应

报道了一种1-(1-乙基-1H-5-吲哚基)-2-苯基-1,2-二酮与氨基胍碳酸氢盐缩合生成互为同分异构体的两种1,2,4-三嗪的反应,并通过运用目标定向合成和核磁的方法,研究了1,2-二酮苯环上不同取代基对反应产品比例的影响.反应总收率为40%~81%,且当不对称1,2-二酮苯环上无取代基时,其生成的同分异构体6-(1-乙基-1H-5-吲哚基)-5-苯基-3-氨基-1,2,4-三嗪(2a)和5-(1-乙基-1H-5-吲哚基)-6-苯基-3-氨基-1,2,4-三嗪(4a)比例为40∶60;当苯环上取代基为吸电子基时,6-(1-乙基-1H-5-吲哚基)-5-(4-硝基苯基)-3-氨基-1,2,4-三嗪(2b)和5-(1-乙基-1H-5-吲哚基)-6-(4-硝基苯基)-3-氨基-1,2,4-三嗪(4b)比例为63∶37;当苯环上取代基为供电子基时,绝大部分生成2系列构型结构.     

1-[3’-(4″-甲氧基苯基)-5’-甲基异噁唑-4’-甲酰基]-4-芳基氨基硫脲及其衍生物的合成

以3,5-二取代异噁唑-4-甲酰肼为基本原料制备关键中间体1-(3-对甲氧基苯基-5-甲基异噁唑-4-基)-4-芳基氨基硫脲(3a～3c);3在不同条件下经关环反应制得含有3,5-二取代异噁唑的2-芳氨基噻二唑(4a～4c),2-芳氨基噁二唑(5a～5c)和3-[3’-(4″-甲氧基苯基)-5’-甲基-异噁唑-4’-基)-4-芳基-1,2,4-三唑-5-硫酮(6a～6c);6与碘甲(乙)烷反应合成了4-芳基-5-[3’-(4″-甲氧基苯基)-5’-甲基异噁唑-4’-基]-3-甲(乙)硫基-1,2,4-三唑(7a～8c),其结构经1H NMR,IR,MS和元素分析表征,其中4,5,7和8未见文献报道。     

新型5-芳基-2-氯-3-取代吡啶衍生物的合成

Vinamidinium盐(1a~1e)与丙二腈(或氰基乙酸乙酯)在甲醇钠催化下经取代反应合成了4-芳基-2-氰基-5-二甲基氨基-2,4-戊二烯腈(2a~2e)[或4-芳基-2-乙氧基羰基-5-二甲基氨基-2,4-戊二烯腈(3a~3e)];2或3在盐酸存在下经环合反应合成了10个新型的5-芳基-2-氯-3-取代吡啶衍生物,收率44%~88%,其结构经1H NMR,13C NMR和MS表征。     

5-苯基-2-(2’-苯基(口恶)唑基-5’)1,3,4-(口恶)二唑及其5-对位取代苯基衍生物的研究

合成了十二个未见报道的5-苯基-2-(2’-苯基(口恶)唑基-5’)1,3,4-(口恶)二唑及其5-对位取代苯基衍生物。测试了它们的紫外光谱、荧光光谱、荧光量于产率和激光转换效率,发现化合物的(?)和(?)与 Hammett 取代基常数|σ_p~+|有线性关系,化合物分子受激发后结构的平面性增加。     

3，6-双（3’-氨基呋咱-4-基）-1，4-二氧杂-2，5-二氮杂环己-2，5-二烯的合成及晶体结构

以3-氨基-4-酰胺肟基呋咱（AAOF）为原料合成出了含能化合物3-氨基-4-酰氯肟基呋咱（ACOF）。用稀碱3％～5％Na2CO3水溶液处理，ACOF脱去一分子HCl生成不稳定中间体3-氨基-4-氰基呋咱的氧化物（ACFO），随后发生歧化反应，生成3，4-二（氨基呋咱基）氧化呋咱（BAFF）及其异构体3，6-双（3’-氨基呋咱-4-基）-1，4-二氧杂-2，5-二氮杂环己-2，5-二烯（BADDD）。用IR、MS、^1H NMR、^13C NMR和元素分析对ACOF的分子结构进行了表征。分子和晶体结构测试表明，BADDD是一具有新颖化学分子结构的化合物。     

Morita-Baylis-Hillman reaction of masked 5-alkylidene-2-cyclopentenones: general entry to 5-alkylidene-2-(hydroxyalkyl)- 2-cyclopentenones

The reaction of masked 5-alkylidene-2-cyclopentenones with aldehydes catalyzed by tributylphosphine in the presence of phenol provided the corresponding Morita-Baylis-Hillman adducts, which were subjected to flash vacuum pyrolysis to afford 5-alkylidene-2-(hydroxyalkyl)-2-cyclopentenones.     

Synthesis of 2-(dibenzosuberen-5-yl)-1,3-dicarbonyl compounds

Reaction of dibenzosuberen-5-ol with 1,3-dicarbonyl compounds catalyzed with scandium(III), copper(II), or indium(III) triflate (5 mol %) afforded 2-(dibenzosuberen-5-yl)-1,3-dicarbonyl compounds in 63–86% yield.     

(R)-(＋)-5-甲基-5-{4-[2-(2-(5-氯吲唑基))乙氧基]苄基}-2,4-噁唑烷二酮的合成及其绝对构型的确定

以(S)-(－)-1-苯乙胺为拆分剂对外消旋的α-羟基酸进行拆分, 得到手性α-羟基酯4, 再与尿素合环、脱甲基保护, 得到关键的手性中间体(R)-(＋)-5-甲基-5-(4-羟基苄基)-2,4-噁唑烷二酮(6). 将化合物6与甲磺酸酯(8)缩合即得具有全新化学结构的标题化合物9 (ee值100%), 其结构经1 H NMR和HRMS确证. 根据拆分盐3的单晶X射线衍射分析结果及由α-羟基酯4与尿素合环生成噁唑烷二酮的反应机理, 确定标题化合物9的绝对构型为R.     

The synthesis of 2-substituted azino-3-(β-D-ribofuranosyl)-5-carboxymethylenethiazolidin-4- ones

2-(1-Isopropylidene)azino-3-β-D-ribofuranosyl-5- methoxycarbonylmethylenethiazolidin-4-one (IV) and 2-(1-methylbenzilidene)azino-3-β-D-ribofuranosyl-5-carboxymethylenethiazolidin-4-one were prepared by independent synthesis utilizing either acid catalyzed fusion of 2-(1-isopropylidene)azino-5-methoxycarbonylmethylenethiazolidin-3(H)-4-one (II) with 1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose, silylation procedure with 2,3,5-tri-O-benzoyl-D-ribofuranosyl bromide or by cyclization of new isopropylidene and/or methylbenzilidene derivatives (VII) of 4-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)thiosemicarbazide (VI) with maleic anhydride and subsequent methylation. The synthetic approach has unambigously established the glycosilation site as well as anomeric configuration, which was additionally derived from pmr spectral data.     

Studies on the synthesis of 2-(2-arylvinyl)thieno[2,3-d]pyrimidines and 5-(2-arylvinyl)triazolothieno[3,2-e]pyrimidines

Synthesis of 2-(2-arylvinyl)thienopyrimidines, by the acid catalyzed condensation of nitriles with thiophene o-aminocarbonyl compounds, the condensation of aldehydes with thiophene o-aminoamides, the base catalyzed condensation of aldehydes with 2-methylthienopyrimidines and by the Wittig condensation of 2-thieno-pyrimidinylmethylphosphonium salts with aldehydes is described. Isomeric 5-methyltriazolothienopyrimidines were found to react, under basic condition, with aldehydes yielding 5-(2-arylvinyl)triazolo[2,3-c]thieno-pyrimidines. While 5-styryltriazolo[4,3-c] isomers resisted acid catalysed isomerization, they were found to isomerize to triazolo[2,3-c]pyrimidines under base catalysis.     

Synthesis of 9-C6H5-3-(π-C5H5)-3,1,2-CoC2B9H10 by cross-coupling reaction of 9-I-3-(π-C5H5)-3,1,2-CoC2B9H10 with C6H5ZnCl catalyzed by palladium complexes

The cross-coupling reaction of 9-I-3-(π-C₅H₅)-3,1,2-CoC₂B₉H₁₀ with organozinc compounds catalyzed by palladium complexes was used to synthesize the first representative ofB-phenyl-substituted carboranes, 9-C₆H₅-3-(π-C₅H₅)-3,1,2-CoC₂B₉H₁₀. Translated fromIzvestiya Akademii Nauk. Seriya Khimicheskaya, No: 6, pp. 1253–1254, June, 1998.     

Pyridine-substituted hydroxythiophenes. V. Preparation of 5-(2-, 3-and 4-pyridyl)-2-hydroxythiophenes

5-(2-, 3- and 4-Pyridyl)-2-t-butoxythiophenes have been prepared in very good yields by Pd(0) catalyzed cross-coupling of the three isomeric bromopyridines with 5-trimethylstannyl-2-t-butoxythiophene derived from 2-bromothiophene via 2-t-butoxythiophene. Dealkylation of 5-(2-, 3- and 4-pyridyl)-2-t-but-oxythiophenes with boron trifluoride etherate in dichloromethane at room temperature led to predominant formation of rearranged products, 5-(2- and 3-pyridyl)-3-t-butyl-3-thiolene-2-ones, together with a small amount of 5-(2- and 3-pyridyl)-2-hydroxythiophenes as a mixture of two tautomeric keto forms in the case of the 2-pyridyl and the 3-pyridyl isomers, and exclusive formation of rearranged product in the case of the 4-pyridyl isomer. However, dealkylation of 2-methoxy-5-(2-, 3- and 4-pyridyl)thiophenes, prepared similarly to the 5-(2-, 3- and 4-pyridyl)-2-t-butoxythiophenes, with boron tribromide under the same reaction conditions as above resulted exclusively in the tautomeric mixture of 5-(2- and 3-pyridyl)-3-thiolene-2-ones and 5-(2- and 3-pyridyl)-4-thiolene-2-ones in the case of the 2-pyridyl and 3-pyridyl isomers. In the case of the 4-pyridyl isomer polymerization took place.     

Synthesis of 2-substituted (+/-)-(2r,3r,5r)-tetrahydrofuran-3,5-dicarboxylic acid derivatives

An efficient synthesis of 2-substituted (+/-)-(2R,3R,5R)-tetrahydrofuran-3,5-dicarboxylic acid derivatives has been developed. Starting from 5-norborne-2-ol, the key intermediate (+/-)-methyl 5,6-exo,exo-(isopropylidenedioxy)-2-oxabicyclo[2.2.1]heptane-3-exo-carboxylate (15) was synthesized in an efficient six-step sequence. The key transformation is the base-catalyzed methanolysis-rearrangement of (+/-)-6,7-exo,exo-(isopropylidenedioxy)-4-exo-iodo-2-oxabicyclo[3.2.1]octan-3-one (14). Further manipulation of the 3-substituent of (+/-)-methyl 5,6-exo,exo-(isopropylidenedioxy)-2-oxabicyclo[2.2.1]heptane-3-exo-carboxylate (15) followed by deprotection of the diol moiety and ring opening catalyzed by RuCl(3)/NaIO(4) gave the title compounds in good yield.     

Modified synthesis of methyl (1R,2R,3E,5R)-3-(hydroxyimino)-5-methyl-2-(1-methylethyl)-cyclohexanecarboxylate from (R)-4-menthen-3-one

A modified stereospecific synthesis of potentially biologically and pharmacologically active methyl (1R,2R,3E,5R)-3-(hydroxyimino)-5-methyl-2-(1-methylethyl)cyclohexanecarboxylate from (R)-4-menthen-3-one was developed using sequential 1,4-conjugate addition of Norman reagent catalyzed by CuI?CBF₃?Et₂O?CCuCl₂ and ozonolysis?Creduction of the intermediate (R,R,R)-vinylmenthone by hydroxylamine hydrochloridein MeOH.     

Palladium complex of 6-(2-hydroxy-5-methylphenyl)-3-(pyridin-2-yl)-1,2,4-triazin-5(2<Emphasis Type="Italic">H</Emphasis>)-one: Synthesis,structure, and catalytic activity

Palladium(II) complex with 6-(2-hydroxy-5-methylphenyl)-3-(pyridin-2-yl)-1,2,4-triazin-5(2H)-one was synthesized for the first time. The ligand was prepared from 3-(pyridin-2-yl)-1,2,4-triazin-5(2H)-one and 4-methylphenol via nucleophilic substitution of hydrogen (S_N^H reaction). The complex was readily soluble in basic medium, and it effectively catalyzed Mizoroki-Heck reaction.